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Insights into seasonal dynamics of bacterial meningitis
Despite remarkable progress in prevention via vaccines, 
bacterial meningitis remains a major global infectious 
disease challenge with high morbidity and mortality.1 
In this issue of The Lancet Global Health, Juliette Paireau 
and colleagues2 present a global meta-analytical study 
of the seasonal dynamics of three major pathogens that 
cause bacterial meningitis worldwide: Streptococcus 
pneumoniae, Neisseria meningitidis, and Haemophilus 
inﬂ uenzae. The study compiled a comprehensive global 
database of national meningitis surveillance data 
from 66 countries and analysed country-level data 
using innovative wavelet analysis. A distinct 12-month 
seasonal incidence pattern was detected in a remarkably 
consistent 96% of 38 countries that had suﬃ  cient 
data for analysis. Also, the study found a consistent 
relationship between the timing of peak bacterial 
meningitis incidence and latitude. Peak meningitis 
incidence was in February to March for countries in the 
meningitis belt of sub-Saharan Africa, with remaining 
countries having peaks in respective winter months 
in the northern and southern hemispheres. The same 
seasonal pattern persisted when meningitis surveillance 
data were broken down for all three species.
The study did not ﬁ nd a diﬀ erence in seasonality after 
introduction of new vaccines, despite a reduction in 
incidence. This is important because, although capsular 
group A epidemics seem to have been eliminated by 
introduction of the group A meningococcal conjugate 
vaccine in the meningitis belt, epidemics caused by 
group C, W, and X continue to occur there.3 Since 
strain distribution undergoes frequent changes both 
because and independent of the impact of vaccination 
programmes, future analysis will be needed to assess 
whether changes in infecting strain aﬀ ect the onset and 
peak meningitis incidence.
Interestingly, there were some diﬀ erences between 
seasonal peaks for the three pathogens in countries with 
such data. For example, in the four countries with both 
H inﬂ uenzae and N meningitidis data, the N meningitidis peak 
preceded that of H inﬂ uenzae by 3–6 weeks. Unexpectedly, 
the peak incidence of bacterial meningitis in Lebanon, a 
country with a Mediterranean climate, is in the hot and 
dry month of May, suggesting that some countries outside 
of sub-Saharan Africa may also have peak meningitis 
incidence associated with hot, dry weather.
All three of these bacterial pathogens are transmitted 
via airborne respiratory droplets, colonise the 
pharyngeal mucosa, and reach the meninges through 
haematogenous spread.4,5 Bacterial meningitis arises 
from an intricate interplay between host, pathogen, 
and environmental factors. On the bacterial side, 
recent studies applying high-resolution genomics have 
identiﬁ ed genetic factors that lead to the emergence 
of virulent pneumococcal and meningococcal strains 
predominantly through homologous recombination 
and phase variation within capsule-encoding and major 
antigen genes.6–8 Much is also known about host genetic 
and behavioural risk factors for bacterial meningitis.5 
Even though the seasonal nature of meningitis has 
been known since at least the 1960s,9 the exact 
mechanisms by which environmental factors exert a 
seasonal inﬂ uence on incidence remain unclear. The 
majority of the meningitis belt lies within an area with 
300–1100 mm annual rainfall that experiences large 
meningococcal epidemics in the dry and dusty months 
of February to April.3 Meningococcal cases typically show 
a precipitous decline with the onset of the rainy season. 
Physical damage to pharyngeal mucosa, concomitant 
viral infections, and changes in normal pharyngeal ﬂ ora 
have been proposed, although not yet established, as 
the cause of these dramatic changes in incidence.5,10
What are the public health implications of Paireau 
and colleagues’ study? First, it demonstrates the utility 
of large global databases to address fundamental 
questions about infectious diseases epidemiology. In this 
case, the data are from national surveillance systems, 
which further underscores the value of public health 
surveillance. In that regard, the study highlights the need 
for strengthened meningitis surveillance in countries 
with limited data such as India, parts of the Middle 
East, and central Asia, primarily to measure disease 
burden and formulate vaccination policy. Second, an 
improved understanding of the complex interplay of 
environmental forces in the pathogenesis of bacterial 
meningitis could help in public health preparedness, 
especially for the 19 meningitis belt countries in Africa 
that experience meningococcal epidemics.3 Third, it 
will be important to determine whether the seasonal 
dynamics demonstrated in this study will change in the 
setting of ongoing climate change.
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In summary, Paireau and colleagues present important 
groundwork on global seasonal dynamics of bacterial 
meningitis. How complex environmental variables, 
the natural dynamics of bacterial meningitis, and 
immunisation programmes will aﬀ ect seasonal and 
long-term temporal changes in bacterial meningitis 
epidemiology warrants additional investigation.
Mustapha M Mustapha, *Lee H Harrison
Microbial Genomic Epidemiology Laboratory, Infectious Diseases 
Epidemiology Research Unit, Graduate School of Public Health and 
School of Medicine, University of Pittsburgh, Pittsburgh, 
PA 15261, USA
lharriso@edc.pitt.edu
We declare no competing interests.
Copyright © Mustapha et al. Open Access article distributed under the terms of 
CC BY.
1 van de Beek D. Progress and challenges in bacterial meningitis. Lancet 
2012; 380: 1623–24.
2 Paireau J, Chen A, Broutin H, Grenfell B, Basta NE. Global trends in seasonal 
dynamics of bacterial meningitis: a time-series analysis. Lancet Glob Health 
2016; 4: e370–77.
3 WHO. Meningococcal disease control in countries of the African meningitis 
belt, 2014. Wkly Epidemiol Rec 2015; 90: 123–31.
4 Henriques-Normark B, Tuomanen EI. The pneumococcus: epidemiology, 
microbiology, and pathogenesis. Cold Spring Harb Perspect Med 2013; 
3: a010215.
5 Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, 
meningococcaemia, and Neisseria meningitidis. Lancet 2007; 
369: 2196–210.
6 Lamelas A, Harris SR, Roltgen K, et al. Emergence of a new epidemic 
Neisseria meningitidis serogroup A Clone in the African meningitis belt: 
high-resolution picture of genomic changes that mediate immune evasion. 
MBio 2014; 5: e01974–14.
7 Mustapha MM, Marsh JW, Krauland MG, et al. Genomic epidemiology of 
hypervirulent serogroup W, ST-11 Neisseria meningitidis. EBioMedicine 2015; 
2: 1447–55.
8 Moore MR, Gertz RE Jr, Woodbury RL, et al. Population snapshot of 
emergent Streptococcus pneumoniae serotype 19A in the United States, 
2005. J Infect Dis 2008; 197: 1016–27.
9 Lapeyssonnie L. Comparative epidemiologic study of meningococcic 
cerebrospinal meningitis in temperate regions and in the meningitis belt in 
Africa. Attempt at synthesis. Med Trop (Mars) 1968; 28: 709–20.
10 Brundage JF. Interactions between inﬂ uenza and bacterial respiratory 
pathogens: implications for pandemic preparedness. Lancet Infect Dis 2006; 
6: 303–12.
